Dishman Carbogen Amcis

Last updated

Dishman Carbogen Amcis Limited
Type Public
Industry Pharmaceuticals
Founded1983
Headquarters Ahmedabad, Gujarat, India [1]
Key people
  • Janmejay R. Vyas (Chairman & Managing Director)
  • Arpit J. Vyas (Global CFO)
  • Himani Dhotre (CEO)
ProductsBulk Drugs, Chemicals
RevenueIncrease2.svg2,440 crore (US$310 million) (FY23) [2]
Decrease2.svg−29 crore (US$−3.6 million) (FY23) [2]
Website www.imdcal.com

Dishman Carbogen Amcis Ltd is an Indian multinational pharmaceutical company specialized in the manufacture of active ingredients and contract development and manufacturing. Dishman employs over 1,000 people worldwide and is listed on the Bombay Stock Exchange (BSE) and National Stock Exchange of India (NSE).

Contents

History

The Dishman Group was founded in 1983 by Shri Janmejay R. Vyas, Managing Director of the Dishman Group. Since the beginning, the focus of the Dishman Group has been on research and development of various in-house technologies for the manufacture of quaternary ammonium compounds (quats) and active pharmaceutical ingredients. The first facility of the Dishman Group was built in 1987 in Naroda; in 1996 the company initiated its expansion at Bavla where it is currently headquartered. Through several acquisitions, [3] the Dishman Group became a global company with multiple manufacturing facilities in India, Europe and China serving pharmaceutical and biopharmaceutical companies.

Company Structure

The Dishman Carbogen Amcis Group operates in two segments: contract research services and marketable molecules such as bulk drugs, intermediates, quaternary ammonium compounds (quats), specialty chemicals and phase transfer catalysts. Dishman operates in four business units:

Locations

Related Research Articles

Dr. Reddy's Laboratories is an Indian multinational pharmaceutical company based in Hyderabad. The company was founded by Kallam Anji Reddy, who previously worked in the mentor institute Indian Drugs and Pharmaceuticals Limited. Dr. Reddy's manufactures and markets a wide range of pharmaceuticals in India and overseas. The company has over 190 medications, 60 active pharmaceutical ingredients (APIs) for drug manufacture, diagnostic kits, critical care, and biotechnology.

Naroda is a fast-growing area in Ahmedabad, northeast of central Ahmedabad in the Indian state of Gujarat.

<span class="mw-page-title-main">Fine chemical</span> Pure chemical substances produced by and for the chemical industry

In chemistry, fine chemicals are complex, single, pure chemical substances, produced in limited quantities in multipurpose plants by multistep batch chemical or biotechnological processes. They are described by exacting specifications, used for further processing within the chemical industry and sold for more than $10/kg. The class of fine chemicals is subdivided either on the basis of the added value, or the type of business transaction, namely standard or exclusive products.

Torrent Pharmaceuticals Ltd is an Indian multinational pharmaceutical company, owned by Torrent Group and headquartered in Ahmedabad. It was promoted by U. N. Mehta, initially as Trinity Laboratories Ltd, and was later renamed Torrent Pharmaceuticals Ltd.

<span class="mw-page-title-main">Cambrex Corporation</span> American pharmaceutical company

Cambrex Corporation is a Contract Development Manufacturing Organisation (CDMO) that provides drug substance, drug product and analytical services across the entire drug lifecycle, as well as active pharmaceutical ingredients (APIs). With over 2,200 employees in 7 countries across 13 locations, Cambrex operates in branded and generic markets for API and dosage form development and manufacturing.

<span class="mw-page-title-main">Lonza Group</span> Swiss pharmaceutical and biotech company

Lonza Group is a Swiss multinational manufacturing company for the pharmaceutical, biotechnology and nutrition sectors, headquartered in Basel, with major facilities in Europe, North America and South Asia. Lonza was established under that name in the late 19th-century in Switzerland. The company provides product development services to the pharmaceutical and biologic industries, including custom manufacturing of biopharmaceuticals and detection systems and services for the bioscience sector.

<span class="mw-page-title-main">Patheon</span>

Patheon is a service brand within Thermo Fisher Scientific’s brand portfolio. Contract development and manufacturing organization (CDMO) services offered under the Patheon brand include small molecule API, biologics, viral vectors, cGMP plasmids, formulation, clinical trials solutions, logistics and commercial manufacturing and packaging. In 2017, Patheon was acquired by Thermo Fisher Scientific to form its Pharma Services business.

A contract manufacturing organization (CMO), more recently referred to as a contract development and manufacturing organization (CDMO) to avoid the acronym confusion of Chief Medical Officer or Clinical Monitoring Organization in the pharma industry, is a company that serves other companies in the pharmaceutical industry on a contract basis to provide comprehensive services from drug development through drug manufacturing. This allows major pharmaceutical companies to outsource those aspects of the business, which can help with scalability or can allow the major company to focus on drug discovery and drug marketing instead.

<span class="mw-page-title-main">Olainfarm</span> Company based in Latvia

Olainfarm AS is a Latvian leading manufacturer in the chemical and pharmaceutical sector of the Baltic States.

Akbarieh, headquarters in Tehran, Iran, is one of the oldest suppliers of pharmaceuticals and fine chemicals and importers to Iran. Established in 1890, the company is still operated by the Akbarieh family. Akbarieh customers are health professionals, and manufacturers of pharmaceuticals, food, cosmetic and feed industries.

Unichem Laboratories was founded in 1944 by Padmabhushan Late Mr. Amrut V Mody, a pioneer in the Indian pharmaceuticals business.

<span class="mw-page-title-main">Grindeks</span> Company based in Riga, Latvia

JSC Grindeks is an internationally operating Latvian pharmaceutical company with headquarters in Riga, Latvia. Its portfolio consists of original products, generics, and active pharmaceutical ingredients. It mostly focuses on cardiovascular, central nervous system, anti-cancer and diabetes medicines. Grindeks is the leading pharmaceutical manufacturer in the Baltic States. In 2021 Grindeks imported products to more than 90 countries.

Teva API is an international pharmaceutical company headquartered in Israel. Teva API is a stand-alone business unit of Teva Pharmaceutical Industries limited, the largest generic drug manufacturer in the world and one of the 15 largest pharmaceutical companies worldwide.

<span class="mw-page-title-main">Aurobindo Pharma</span> Indian multinational pharmaceutical company

Aurobindo Pharma Limited is an Indian multinational pharmaceutical manufacturing company headquartered in HITEC City, Hyderabad, India. The company manufactures generic pharmaceuticals and active pharmaceutical ingredients. The company’s area of activity includes six major therapeutic and product areas: antibiotics, anti-retrovirals, cardiovascular products, central nervous system products, gastroenterologicals, and anti-allergics. The company markets these products in over 125 countries. Its marketing partners include AstraZeneca and Pfizer.

<span class="mw-page-title-main">MacFarlan Smith</span>

MacFarlan Smith is a pharmaceutical manufacturing company based in Edinburgh, Scotland, founded in 1815. After its sale from Johnson Matthey in June 2022 to Altaris Capital Partners, Macfarlan Smith rebranded as Veranova. Veranova is a CDMO specialising in the development and manufacturing of specialist and complex APIs. Veranova has facilities across Europe, North America and Asia.

ABA Chemicals is a Chinese chemical manufacturing company headquartered in Taicang. The company was founded in 2006 as Suzhou ABA Chemicals, and is traded on the Shenzhen Stock Exchange as 300261.

AMRI is a contract research and manufacturing organization that provides drug discovery, development, cGMP manufacturing and aseptic fill and finish to the pharmaceutical and biotechnology industries. Founded in 1991, AMRI operates in the United States, Europe and Asia, with its headquarters located in Albany, New York. AMRI has announced deals and collaborations with such companies as Pfizer Inc., Merck & Co., Eli Lilly and Co., Takeda, Genentech, Bristol-Myers Squibb Co. and GE.

Alembic Pharmaceuticals Ltd. is an Indian multinational pharmaceutical company headquartered in Vadodara. It is involved in manufacture of pharmaceutical products, pharmaceutical substances and intermediates. It is also termed to be a market leader in macrolides segment of anti-infective drugs in India.

<span class="mw-page-title-main">Laurus Labs</span> Indian pharmaceutical company

Laurus Labs is an Indian multinational pharmaceutical and biotechnology company headquartered in Hyderabad. Its focus areas include active pharmaceutical ingredients (APIs), generic formulations, custom synthesis (CDMO), biotechnology. veterinary APIs and agro chemicals. The company was founded in 2005 by Dr. Satyanarayana Chava.

<span class="mw-page-title-main">Divi's Laboratories</span> Indian pharmaceutical company

Divi's Laboratories Limited is an Indian multinational pharmaceutical company and producer of active pharmaceutical ingredients (APIs) and intermediates, headquartered in Hyderabad. The company manufactures and custom synthesizes generic APIs, intermediates. The company also manufactures and supplies nutraceutical ingredients through its subsidiary, Divi's Nutraceuticals. Divi's Laboratories is India's fourth largest publicly-listed pharmaceutical company by market capitalization.

References

  1. "DISHMAN PHARMACEUTICALS & CH (DISH:Natl India): Stock Quote & Company Profile - BusinessWeek". Investing.businessweek.com. Archived from the original on 18 January 2013. Retrieved 23 December 2011.
  2. 1 2 "Dishman Carbogen Amcis Ltd Q4 FY2023 consolidated loss at Rs. 70.72 crores". EquityBulls. 23 May 2023. Retrieved 24 June 2023.
  3. "East meets West". Archived from the original on 4 March 2016. Retrieved 28 June 2012.
  4. "Dishman Veenendaal". Archived from the original on 27 March 2018. Retrieved 26 July 2019.
  5. http://dishmancare.com/
  6. http://www.carbogen-amcis.com
  7. "Archived copy" (PDF). Archived from the original (PDF) on 26 May 2012. Retrieved 28 June 2012.{{cite web}}: CS1 maint: archived copy as title (link)
  8. http://www.pharmtech.com/pharmtech/Ingredients+Insider/CMOs-Invest-in-High-Potency-Manufacturing/ArticleStandard/Article/detail/534703 [ dead link ]
  9. "Archived copy" (PDF). Archived from the original (PDF) on 4 March 2016. Retrieved 28 June 2012.{{cite web}}: CS1 maint: archived copy as title (link)
  10. 1 2 "Dishman buys Swiss pharma major Carbogen". Business Standard India. 24 August 2006.
  11. CONTRACT, PHARMA. "Completes successful Swissmedic inspection at Vionnaz, Switzerland". Contract Pharma. Retrieved 10 June 2022.
  12. "Carbogen Amcis Acquires Creapharm Parenterals".
  13. "Indian CMO expands in Europe and Middle East".